Sagility India Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹28 - ₹30
- Lot size
- 500 shares
- Issue amount
- ₹2,106.4 cr
- Total subscription
- 3.2×
- Opens
- 5 Nov 2024
- Closes
- 7 Nov 2024
- Allotment
- 9 Nov 2024
- Listing
- 12 Nov 2024
Offer at a glance
Issue overview
- Issue size
- 70,21,99,262 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹14,000
- Fresh issue
- ₹0 cr
- Offer for sale
- ₹2,106.6 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹15,000
- Issue type
- Bookbuilding IPO
- Shares before issue
- 4,68,13,28,413
- Shares after issue
- 4,68,13,28,413
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 500 | ₹15,000 |
| sHNI | 14 | 7,000 | ₹2,10,000 |
| bHNI | 67 | 33,500 | ₹10,05,000 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| HNIs(10L +) | 10,004 | 2,846 |
| HNIs (2-10L) | 5,002 | 11,285 |
| RETAIL | 1,40,060 | 5,49,274 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 630.27 | 2,216.05 |
| RETAIL | 210.09 | 874.51 |
| HNIs 2+ | 105.04 | 252.76 |
| HNIs 10+ | 210.09 | 355.35 |
| EMPLOYEES | 5.7 | 21.39 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Jun-24 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 0.05 | 0.53 | 0.33 |
| ROE | 0 | 0 | 0 |
| ROCE | 0 | 0 | 0 |
| RONW | 0.29 | 3.54 | 2.31 |
| PRE IPO(PE) | 61.52 | 0 | 0 |
| POST IPO(PE) | 61.52 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Sagility India Limited (formerly Berkmeer India Private Limited) provides healthcare-focused services to U.S. health insurers (payers) and medical service providers such as hospitals, doctors, diagnostics, and medical technology companies. Its solutions include claims processing, payment accuracy checks, clinical management, and revenue cycle management to help streamline billing and healthcare cost settlements. The company also supports Pharmacy Benefit Managers (PBMs) in managing prescription drug coverage. Sagility serves only U.S.-based customers, with strong long-term relationships—its top five customer groups have an average association of 17 years, and as of January 2024, it worked with five of the top ten U.S. payers. The company added 20 new clients across FY 2023 and FY 2024 and had a workforce of 35,044 employees as of March 31, 2024, of which 60.52% were women, including 1,687 certified professionals such as medical coders, registered nurses, and specialists in dentistry, surgery, and pharmacy.
Strengths
- Leadership in U.S. Healthcare Market: Sagility maintains a strong foothold in the expanding U.S. Payer and Provider services industry, driven by growing outsourcing demand and essential service offerings.
- Extensive Domain Experience: With over two decades of specialization, the company combines deep operational expertise and tech-enabled healthcare solutions across both segments.
- Advanced and Scalable Tech Infrastructure: Proprietary RPA-, analytics-, and AI-powered platforms enable efficient, end-to-end service delivery and revenue cycle optimization.
Risk factors
- High Competitive Pressure: Operates in a highly competitive U.S. healthcare services market, where loss of edge could impact growth and profitability.
- Geographic Concentration Risk: Heavy dependence on the U.S. market makes the company susceptible to country-specific economic or regulatory shifts.
- Intangible Asset Exposure: Large share of assets in goodwill and intangibles; any impairment could weaken financial strength and credibility.
Promoters
Sagility B.V
Sagility Holdings B.V
Registrar & documents
Lead manager
ICICI Securities Limited, IIFL Capital Services Limited, Jefferies India Private Limited, J.P. Morgan India Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
No. 23 & 24, AMR Tech Park, Building 2A, First Floor, Hongasandara Village, Off Hosur Road, Bommanahalli, Bengaluru - 560 068
+91- 80-7125 150
[email protected]Company website ↗Frequently Asked Questions
What is Sagility India IPO GMP today?
As of today, Sagility India IPO Grey Market Premium (GMP) is reported at +₹0.3 per share. Based on the upper price band of ₹30, the estimated listing price is ₹30.3 (+1.0% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Sagility India IPO?
The minimum bid lot size for Sagility India IPO is 500 shares. At the cut-off price of ₹30 per share, retail investors need a minimum application amount of ₹15,000 per lot. Retail applicants can apply for a maximum of 13 lots (up to ₹2,00,000).
When will Sagility India IPO allotment status be announced?
The allotment status for Sagility India IPO is scheduled to be finalized on 9 Nov 2024. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Link Intime India Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Sagility India IPO allotment status online by PAN?
To check Sagility India IPO allotment status: 1) Visit the registrar portal (Link Intime India Private Limited) or the BSE IPO allotment page. 2) Select 'Sagility India Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.